Market capitalization of bluebird bio (BLUE)

Market cap: NZ$0.15 Billion

As of October 2024 bluebird bio has a market cap of NZ$0.15 Billion. This makes bluebird bio the world's 8811th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

End of year Market Cap

End of Day market cap according to different sources

On Oct 17th, 2024 the market cap of bluebird bio was reported to be:

NZ$0.15 Billion

by Yahoo Finance

NZ$0.15 Billion

by CompaniesMarketCap

NZ$0.15 Billion

by Nasdaq

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
BioMarin Pharmaceutical BMRN	NZ$21.80 B	13,919.53%	🇺🇸 USA
Acceleron Pharma XLRN	NZ$18.02 B	11,487.55%	🇺🇸 USA
Sanofi SNY	NZ$228.72 B	146,935.88%	🇫🇷 France
Sangamo Therapeutics SGMO	NZ$0.32 B	106.52%	🇺🇸 USA
Merck MRK	NZ$458.71 B	294,788.58%	🇺🇸 USA
GlycoMimetics GLYC	NZ$16.85 M	-89.17%	🇺🇸 USA